M118

· Momenta Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M118, covering 2017-12-12 to 2017-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) [Phase 2]